Leucadia National Corporation »

Macrogenics shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Macrogenics (MGNX) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Macrogenics

Tip: Access up to 7 years of quarterly data

All positions including Macrogenics held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Macrogenics by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.0M 1.8M 1.61
2024-09-30 $82k 25k 3.29
2024-06-30 $411k 97k 4.25
2022-12-31 $9.8k 13k 0.74

More positions owned by Leucadia National Corporation

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Iren Ordinary Shares (IREN)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Citigroup Com New (C)
Amazon (AMZN)
Spdr Series Trust State Street Spd (XBI)
Apple (AAPL)
Select Sector Spdr Tr State Street Ene (XLE)
Alphabet Cap Stk Cl A (GOOGL)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)

View all positions for Leucadia National Corporation

Top funds holding Macrogenics

Armistice Capital
Vanguard Group
Frazier Life Sciences Management
Renaissance Technologies
Acadian Asset Management
Millennium Management
Leucadia National Corporation
Daniel D. Thurber
BlackRock
Marshall Wace
Jane Street
Jacobs Levy Equity Management
Connor, Clark & Lunn Investment Management
Jpmorgan Chase & Co
Two Sigma Advisers

View all funds holding Macrogenics